Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC)

Burcu Armutlu; İlknur Hoş

doi:10.17776/csj.640079

EN

Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC)

Abstract

Lung cancer is one of the leading causes of cancer - related deaths. Recently, radiotherapy is being used extensively for the treatment of patients suffering from cancer. Proton therapy is a very suitable form of radiation therapy for tumors that occur in the vicinity of critical tissues such as lung, due to the unique characteristics of the protons used in the treatment. In this study, a geometry model with lung, heart, tumor and bone structures in a water phantom is modeled with the Monte Carlo simulation tool vGATE, version of 7.2. With this simulation, the accumulated dose are calculated for each organ.

Keywords

GATE,Lung cancer,Monte Carlo,Proton therapy

References

[1] Globocan 2018 Graph production: IARC, World Health Organization. Adress: http://gco.iarc.fr/today. Retrieved September 23, 2019.
[2] Peh W.C.G., History of the discovry of x ray, part I- Rontgen and his discovery of x ray, Singapore Med. J., 36 (1995) 437-441.
[3] Khan M.F., Gibbons J.P., (2014), Khan’s The Physics of Radiation Therapy (Fifth Edition), Lippin- cott Williams & Wilkins, Philadelphia, USA: LWW.com
[4] Wilson R.R., Radiological use of fast protons, Radiology, 47 (1946) 487-491.
[5] Lawrence J.H., Tobias C.A., Born J.L., Mccombs R.K., Roberts J.E., Anger H.O., Lowbeer B.V., Huggıns C.B., Pituitary irradiation with high energy proton beams: a preliminary report, Cancer Res., 18-2 (1958) 121-34.
[6] Gragoudas E., Li W., Goitein M., Lane A.M., Munzenrider J.E., Egan K.M., Evidence-based estimates of outcome in patients irradiated for intraocular melanoma, Arch Ophthalmol 10-12 (2002) 1665-71.
[7] Particle Therapy Co-Operative Group (PTCOG) - An organisation for those interested in proton, light ion and heavy charged particle radiotherapy. Adress:https://www.ptcog.ch/index.php/facilities-in-operatio. Retrieved September 30, 2019.
[8] Mesko S., Gomez D., Proton Therapy in Non-small Cell Lung Cancer, Curr. Treat. Options in Oncol., 19-12 (2018) 76. doi: https://doi.org/ 10.1007/s11864-018-0588-z.
[9] Cozzi L., Fogliata A., Lomax A., Bolsi A., A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours, Radiother Oncol., 61-3 (2001) 287–297.
[10] Macdonald O.K., Kruse J.J., Miller J.M., Garces Y.I., Brown P.D., Miller R.C., Foote R.L., Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis, Int J Radiation Oncol. Biol. Phys., 75-3 (2009) 950–958.

[11] Kadoya N., Obata Y., Kato T., Kagiya M., Nakamura T., Tomoda T., Takada T., Takayama K., Fuwa N., Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small cell lung cancer, Int J Radiat Oncol Biol Phys., 79 (2011) 1225–31.
[12] Roelofs E., Engelsman M., Rasch C., Persoon L., Quamhiyeh S., Ruysscher D.D., Verhaegen F., Pijls J.M., Lambin P., Rococo consortium, Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer, J Thorac Oncol., 7-1 (2012) 165–76. doi: 10.1097 / JTO.0b013e31823529fc.
[13] Paganetti H., Jiang H., Lee S.Y., Kooy H.M., Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility, Med. Phys., 31-7 (2004) 2107–2118. doi: https://doi.org/10.1118/1.1762792.
[14] Van Goethem M.J., Van Der Meer R., Reist H.W., Schippers J.M., Geant4 simulations of proton beam transport through a carbon or beryllium degrader and following a beam line, Phys. Med. Biol., 7-54 (2009) 5831–5846. doi:https://doi.org/10.1088/0031-9155/54/ 19/011.
[15] Aso T., Kimura A., Tanaka S., Yoshida H., Kanematsu N., Sasaki T., Akagi T., Veriﬁcation of the Dose Distributions With GEANT4 Simulation for Proton Therapy, IEEE Transactions on Nuclear Science, 52-4 (2005) 896–901. doi: https://doi.org/10. 1109/tns.2005.852697.
[16] Allison J., Amako K., Araujo H., Apotolakis J., Geant4 developments and applications, IEEE Trans.Nucl.Sci., 53-1 (2006) 270-278.
[17] Clasie B., Depauw N., Fransen M., Gom C., Panahandeh H.R., Seco J., et al.: Golden beam data for proton pencil-beam scanning. Phys. Med. Biol. 57-5 (2012). doi:https://doi.org/10.1088/ 0031-9155/57/5/1147.
[18] Users Guide V7.2 From GATE collaborative documentation wiki. Adress: http://www.opengatecollaboration.org/sites/default/files/GATE-UsersGuideV7.2.pdf. Retrieved September 13, 2019.
[19] Agostinelli S., Allison J., Amako K. al, Apostolakis J., Araujo H., Arce P., Asai M., Axen D., Banerjee S., Barrand G., GEANT4—a simulation toolkit, Nucl. instruments methods Phys. Res. Sect. A Accel. Spectrometers, Detect. Assoc. Equip., 506 (2003) 250–303.
[20] GEANT4 a simulation toolkit. Adress: https://geant4.web.cern.ch/. Retrieved: November 19, 2019.
[21] Tan H.Q., Phua J.H., Tan L., Ang K.W., Lee J., Bettiol A.A., Geant4 Simulation for Commissioning of Proton Therapy Centre, World Congress on Medical Physics and Biomedical Engineering 2018, IFMBE Proceedings, 68-1 (2018) 583-587. doi:https://doi.org/10.1007/978-981-10-9035-6_108.
[22] Cirrone G.A.P., Cuttone G., Nigro S.L., Guatelli S., Mascialino B., Pia M.G., Raffaele L., Russo G., Implementation of a New Monte Carlo GEANT4 Simulation Tool for the Development of a Proton Therapy Beam Line and Veriﬁcation of the Related Dose Distributions, IEEE Transactions on Nuclear Science, 52-1 (2005) 262-265. doi:10.1109/TNS.2004.843140.
[23] Cirrone, G.A.P., Cuttone, G., D. Battaglia L., Calabbretta L., Celona F., Di R., Lojacono P., Maggiore M., Mongelli V., Nigro L.S., Piazza L.A.C., Patti V.I., Raffaele L., Re M., Rifuggiato D., Russo G.,Sabini M.G, Salamone V., Valastro L.M., A 62 MeV Proton beam for the treatment of ocular melanoma at Laboratori Nazionali del Sud-INFN (CATANIA), IEEE Nuclear Science Symposium. Conference Record, 5 (2003) 3658-3662. doi:https://doi.org/10.1109/NSSMIC.2003.1352701.
[24] Gray H., Gray’s Anatom, 39th ed. Londo: Churchill; (2005) 997-1003.
[25] Kramer G.H., Capello K., Bearrs B., Lauzon A., Normandeau L., Linear dimensions and volumes of human lungs obtained from CT images. Health Phys., 102-4 (2012) 378-83. doi:10.1097/HP.0b013e31823a13f1.
[26] International Commission on Radiation Units and Measurement)(ICRU). Adress:https://icru.org/. Retrieved September 13, 2019.
[27] Rene B. and Fons R., ROOT An Object Oriented Data Analysis Framework, Proceedings AIHENP'96 Workshop, Lausanne, Nucl. Inst. & Meth. in Phys. Res. A., 389 (1997) 81-86.
[28] Rinecker Proton Therapy Center Third Annual Report Establishing Proton Cancer Therapy in Europe. Adress: https://www.rptc.de/en/information/latest-news/progress-reports/news-progress-reports-detail/rinecker-proton-therapy-center-third-annual-report-establishing-proton-cancer-therapy-in-europe.html. Retrieved September 10 (2019).

Details

Primary Language

English

Subjects

-

Journal Section

Research Article

Authors

Burcu Armutlu This is me
0000-0001-8305-0932
Türkiye

İlknur Hoş ^*
0000-0002-7678-1101
Türkiye

Publication Date

December 31, 2019

Submission Date

October 30, 2019

Acceptance Date

November 22, 2019

Published in Issue

Year 2019 Volume: 40 Number: 4

DOI

https://doi.org/10.17776/csj.640079

IZ

https://izlik.org/JA52NA24ER

APA

Armutlu, B., & Hoş, İ. (2019). Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC). Cumhuriyet Science Journal, 40(4), 909-916. https://doi.org/10.17776/csj.640079

AMA

1.Armutlu B, Hoş İ. Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC). CSJ. 2019;40(4):909-916. doi:10.17776/csj.640079

Chicago

Armutlu, Burcu, and İlknur Hoş. 2019. “Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC)”. Cumhuriyet Science Journal 40 (4): 909-16. https://doi.org/10.17776/csj.640079.

EndNote

Armutlu B, Hoş İ (December 1, 2019) Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC). Cumhuriyet Science Journal 40 4 909–916.

IEEE

[1]B. Armutlu and İ. Hoş, “Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC)”, CSJ, vol. 40, no. 4, pp. 909–916, Dec. 2019, doi: 10.17776/csj.640079.

ISNAD

Armutlu, Burcu - Hoş, İlknur. “Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC)”. Cumhuriyet Science Journal 40/4 (December 1, 2019): 909-916. https://doi.org/10.17776/csj.640079.

JAMA

1.Armutlu B, Hoş İ. Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC). CSJ. 2019;40:909–916.

MLA

Armutlu, Burcu, and İlknur Hoş. “Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC)”. Cumhuriyet Science Journal, vol. 40, no. 4, Dec. 2019, pp. 909-16, doi:10.17776/csj.640079.

Vancouver

1.Burcu Armutlu, İlknur Hoş. Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC). CSJ. 2019 Dec. 1;40(4):909-16. doi:10.17776/csj.640079

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December

Proton Therapy Simulations by GATE in the Treatment of Non-Small Cell Lung Cancer (NSCLC)

Abstract

Keywords

Abstract

References

Details

Primary Language

Subjects

Journal Section

Authors

Publication Date

Submission Date

Acceptance Date

Published in Issue

DOI

IZ

Cite